Scarica l'app Stockscreener
104.89
0.20%
0.21
Pre-mercato:
104.33
-0.56
-0.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Ken Griffin Increased His Position in This Dividend King by a Whopping 546% in Q2. Here's Why It's Still a Buy. - The Motley Fool
StoneX reiterates Buy on Abbott Labs stock ahead of earnings By Investing.com - Investing.com India
Abbott Laboratories stock: TD Cowen sets a USD 135.00 target for Abbott Laboratories stock - ad-hoc-news.de
TD Cowen on Abbott Labs (ABT): 'The Stage is Set for a Stronger 2H' - StreetInsider
Reasons to Add STE Stock to Your Portfolio Right Now - Zacks Investment Research
Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Is it Apt to Retain Medtronic Stock in Your Portfolio Now? - Zacks Investment Research
Pregnancy Tests Recalled Globally Over False Positives - Gizmodo
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research
Abbott Laboratories To Go Ex-Dividend On October 15th, 2026 With 0.63 USD Dividend Per Share - Moomoo
Abbott Laboratories stock may move 4.7% on earnings release - Investing.com
Global Microbiology Testing Market to Grow Rapidly at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance? - Zacks Investment Research
Medtronic Pays More Today. Abbott Raises Its Dividend Faster. Which Stock Wins? - 24/7 Wall St.
SimpleScreen CRC Launch Could Be A Big Moment For Abbott Stock - Simply Wall Street
Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings? - TradingView
Want Passive Income for Life? Here Are 2 Dividend Stocks to Buy and Never Sell - The Motley Fool
Abbott (ABT) Gains As Market Dips: What You Should Know - Zacks Investment Research
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Abbott Laboratories (NYSE:ABT): A Quality Stock With Durable Fundamentals - ChartMill
Freenome to Present New Validation Data for Next-Generation CRC Screening Test in Late-Breaking Oral Presentation at ACG 2026 - GlobeNewswire Inc.
Abbott Laboratories is More than a Dividend Stock. Here’s Why. - Yahoo Finance
What Is Abbott Laboratories (ABT) Telling Investors With Its New Product Push? - Simply Wall Street
Lake County-based Abbott to pay nearly $385 million over claims it made baby formula in leaky, unsanitary plant - Lake and McHenry County Scanner
Abbott Laboratories (ABT) Debuts Ensure Max Protein Powder With Creatine And HMB - Yahoo Finance
History Says Abbott Stock Could More Than Double by 2036. Here’s Why I Just Added It to My Portfolio. - The Motley Fool
Abbott (ABT) Stock Could Be 24% Overvalued After Heart Failure News - Yahoo Finance
Abbott Laboratories (ABT), Why Is Fresh Attention Building Around It? - Simply Wall Street
A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens - The Motley Fool
Cancer Stocks to Consider as Oncology Innovation Accelerates - Zacks Investment Research
Is it the Right Time to Hold TNDM Stock in Your Portfolio? - Zacks Investment Research
China Adult Feeding Tubes and Formula Market Outlook to 2033Revenue, Volume, Pricing, and Company Share | Forecast Data Reveals Market Entry and Expansion Opportunities - GlobeNewswire Inc.
Is it the Right Time to Add Phibro Stock to Your Portfolio? - Zacks Investment Research
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Zacks Investment Research
Is Abbott Laboratories (ABT) a Dividend Bargain After Its 2026 Selloff? - Yahoo Finance
Abbott Laboratories Contamination Lawsuit Ends in $385 Million Settlement — But Nobody's Admitting Anything - https://www.lawnews.co.uk/
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Zacks Investment Research
What Will the Libre Duo Launch Mean for Abbott Laboratories (NYSE:ABT)? - Kalkine Media
Abbott Laboratories stock: FDA approves new CardioMEMS capabilities - AD HOC NEWS
Did Heart Failure Device Updates Just Shift Abbott Stock’s Investment Narrative? - Simply Wall Street
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Better Dividend Play for Retirees: MDT or ABT? One Delivers Significantly More Yield - 24/7 Wall St.
Abbott Laboratories stock trades 26.5 percent below its yearly high - AD HOC NEWS
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown? - Zacks Investment Research
Redburn upgrades Abbott Laboratories stock to Buy - AD HOC NEWS
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
Grace Groner bought three $60 shares of Abbott Laboratories in 1935 and worked there 43 years; she left more than $7 million to benefit Lake Forest College students when she died at 100 - Parade Magazine
AG Fitch announces $384M false claims settlement with Abbott Laboratories - Picayune Item
0.73%
0.49%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):